Spanish researchers identify protein driving melanoma malignancy

By The Science Advisory Board staff writers

August 3, 2022 -- Several proteins are involved in the progression of melanoma, and one in particular, PDIA6, drives malignancy, researchers at the Centre for Genomic Regulation (CRG) in Barcelona found.

Using mice, the team found that melanoma cells with reduced levels of PDIA6 had an impaired ability to metastasize to the lung and that PDIA6 promoted melanoma malignancy by binding to RNA molecules inside the tumor's cell (Nucleic Acids Research, July 15, 2022).

They used RNA fishing, also known as RNA interactome capture, to make this determination, which involves fishing out all messenger RNAs in a cell. They could then see which proteins were attached to the cells and which proteins were involved in the diversity of RNA-binding activities taking place inside the cells.

When comparing tumor and non-tumor cells, RNA fishing helped the researchers identify which proteins played important roles in cancer progression and how they worked. With more research, this information could help with the development of new therapeutic compounds that prevent the spread of melanoma from one part of the body to another. Not only that, if it's discovered PDIA6 also binds to RNA in other cancer types, this could lead to a therapeutic strategy that targets the same mechanism of action across different tumors.

Analysis of nanoparticles, cancer cells could aid development of nanoparticle-based drugs
Researchers have identified biomarkers that predict whether different types of cancer cells will take up specific nanoparticles, potentially helping to...
Nanoparticles-vaccine combination kills melanoma cancer cells
Charged nanoparticles combined with a vaccine are effective in eliminating melanoma tumors or extending the life span of cancerous mice, according to...
Single-cell analyses shed light on drug resistance of melanoma brain metastases
Using single-cell genetic analyses of frozen brain samples, Columbia University researchers have uncovered evidence of how melanoma brain metastases evade...
RNA molecules identified as potential ‘common driver’ of cancer progression
Moffitt Cancer Center researchers have challenged the widely held view that protein structure and function are the key drivers of cancer development....
Limiting gene interactions can prevent melanoma
When it comes to melanoma, a new study published this month in the journal Nature Communications found that limiting interactions of the...

Copyright © 2022 scienceboard.net


Conferences
Glasgow International Health Festival
August 24-27
Glasgow, Glasgow City United Kingdom
Pharma Competitive Intelligence Conference and Exhibition
September 21-22
Newark, New Jersey United States
BioProcess International (BPI) Conference
September 27-30
Boston, Massachusetts United States
Laboratory Products Association Annual Meeting
October 1-4
Scottsdale, Arizona United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter